Latest Research Collaboration News

Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.

Nimy Resources advances its Mons Project with significant high-grade copper and gallium mineralisation confirmed at Masson and Block 3 East prospects, supported by a successful capital raise and a CSIRO research grant.

Optiscan Imaging Ltd reported a productive December quarter, marked by key product developments, strategic partnerships, and a stronger cash position, setting the stage for growth in medical and veterinary imaging markets.

PainChek Ltd reports robust growth with 100,000 contracted licences globally and positive FDA clearance progress, alongside a promising launch of its Infant App targeting a vast new market.

Constellation Resources reports promising drill results at its newly acquired Ularring Copper Gold Project and significantly expands its natural hydrogen exploration acreage in Western Australia, partnering with CSIRO to enhance prospectivity studies.

BlinkLab has launched its pivotal FDA registrational study for its AI-driven autism diagnostic app, BlinkLab Dx 1, following positive FDA feedback and promising preliminary results.

Amplia Therapeutics reports encouraging progress in its Phase 2a ACCENT trial for pancreatic cancer, with nine confirmed partial responses and ongoing patient recruitment. The company also strengthens its financial position with a $13 million capital raise to support further clinical development.

ClearVue Technologies has secured key manufacturing and distribution agreements across the Middle East, China, and the UK, while acquiring ROOTS Sustainable Agricultural Technologies to bolster its net zero ag-tech solutions.

Mineral Commodities Ltd reported a steep net loss of USD 65.1 million for H1 2024, driven by operational disruptions at its Tormin mine and strategic moves including the sale of its Skaland Graphite Project.

Noxopharm’s December 2024 quarterly report reveals expanding global interest in its Sofra technology through new Material Transfer Agreements and a strengthened cash position following a significant R&D tax rebate.

Singular Health has secured a pivotal MoU with Miami-based Provider Network Solutions and raised $3.7 million to propel its 3Dicom software towards a US commercial pilot, supported by the appointment of esteemed radiologist Dr. Ronny Low.

Invex Therapeutics reports encouraging results from its collaboration with Tessara Therapeutics, showing Exenatide’s potential to improve neuronal survival in a 3D human brain model of Alzheimer's disease. The company maintains a stable cash position while exploring new neurological partnerships.